Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Nature Medicine 12, 4 (1 January 2006) | doi:10.1038/nm0106-4b;
Unchecked by guidelines, Indian stem cell scientists rush ahead
Abstract
With all eyes on the stem cell controversy in South Korea, an Indian physician announced that she had used embryonic stem cells to treat 100 individuals, without ethical oversight from India's regulatory agencies. Geeta Shroff, director of the Delhi-based infertility clinic Nutech Mediworld, said at a press conference on 16 November that her team had injected stem cells to treat heart, nerve and immune disorders and injuries.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).